semaglutide original use Obesity Drugs Are Moving Way Past Ozempic Dr. Reddy's Laboratories said on

Supporting Natural Appetite Control Without Medication Probiotic strains that boost GLP-1 might help you stay full for longer

Starting January 2026, you may have an alternative to the injection: CV Risk Reduction: Alternative Coverage Pathway Wegovy is the only obesity medication FDA-approved to reduce cardiovascular risk (March 2024)

In REDEFINE 1, adults with obesity or overweight (without diabetes) treated with CagriSema had a mean body weight reduction of 20.4% at 68 weeks under the treatment-policy estimand, compared with 3.0% on placebo

It is distinct from Rybelsus, which is also oral semaglutide but is licensed at lower doses (3 mg, 7 mg, 14 mg) for type 2 diabetes rather than weight loss

Although our trial focused on CV events, many chronic diseases would benefit from effective weight management. This seems to me to be much more like marketing language than anything resembling a scientific discussion